« Previous
Next »
Lung Cancer
Volume 69, Issue 2
, Pages 239-244
, August 2010
Aberrant promoter methylation of FBLN-3 gene and clinicopathological significance in non-small cell lung carcinoma
References
- . Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106–130
- . Focus on lung cancer. Cancer Cell. 2002;1:49–52
- . DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 2000;16:168–174
- . The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002;3:415–428
- . DNA methylation analysis: a powerful new tool for lung cancer diagnosis. Oncogene. 2002;21:5450–5461
- . Gene-promoter hypermethylation as a biomarker in lung cancer. Nat Rev Cancer. 2004;4:707–717
- . Silencing of genes by promoter hypermethylation: key event in rodent and human lung cancer. Carcinogenesis. 2005;26:1481–1487
- . Fibulins: a versatile family of extracellular matrix proteins. Nat Rev Mol Cell Biol. 2003;4:479–489
- . An overexpressed gene transcript in senescent and quiescent human fibroblasts encoding a novel protein in the epidermal growth factor-like repeat family stimulates DNA synthesis. Mol Cell Biol. 1995;15:120–128
- Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker. Int J Cancer. 2009;124:1727–1735
- Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation. Clin Cancer Res. 2007;13:4336–4344
- . The role of angiogenesis in tumor growth. Semin Cancer Biol. 1992;3:65–71
- . Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995;1:27–31
- . Angiogenesis and cancer metastasis. Cancer J. 2000;6:S134–S141
- . Regulators of angiogenesis. Annu Rev Physiol. 1991;53:217–239
- . Fibulins: multiple roles in matrix structures and tissue functions. Cell Mol Life Sci. 2009;66:1890–1902
- . Fibulins and cancer: friend or foe?. Trends Mol Med. 2005;11:336–340
- Downregulation of several fibulin genes in prostate cancer. Prostate. 2007;67:1770–1780
- . Loss of fibulin-2 expression is associated with breast cancer progression. Am J Pathol. 2007;170:1535–1545
- Fibulin 1 is downregulated through promoter hypermethylation in gastric cancer. Br J Cancer. 2008;99:2083–2087
- . The context and potential of epigenetics in oncology. Br J Cancer. 2009;100:571–577
- . Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res. 1998;72:141–196
- . Mechanisms underlying epigenetically mediated gene silencing in cancer. Semin Cancer Biol. 2002;12:331–337
- . Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med. 2003;349:2042–2054
- . DNA methylation and cancer. J Clin Oncol. 2004;22:4632–4642
PII: S0169-5002(09)00537-6
doi: 10.1016/j.lungcan.2009.10.009
© 2009 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
Lung Cancer
Volume 69, Issue 2
, Pages 239-244
, August 2010
